North American MS Drugs Market, Forecast to 2027 by Drug Type, Class & Category; RoA; MS Type; Distribution Channel; and Country
December 15, 2021 08:53 ET
|
Research and Markets
Dublin, Dec. 15, 2021 (GLOBE NEWSWIRE) -- The "North America Multiple Sclerosis Drugs Market 2020-2027" report has been added to ResearchAndMarkets.com's offering. The North American multiple...
Global Multiple Sclerosis Drugs Market Report 2021: Market is Expected to Reach $25.95 Billion in 2025 - Long-term Forecast to 2030
December 13, 2021 06:53 ET
|
Research and Markets
Dublin, Dec. 13, 2021 (GLOBE NEWSWIRE) -- The "Multiple Sclerosis Drugs Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. ...
Global Multiple Sclerosis Drugs Market (2020 to 2027) - Focus on Immunomodulators and Immunosuppressants
December 10, 2021 06:38 ET
|
Research and Markets
Dublin, Dec. 10, 2021 (GLOBE NEWSWIRE) -- The "Global Multiple Sclerosis Drugs Market 2020-2027" report has been added to ResearchAndMarkets.com's offering. The global multiple sclerosis drugs...
Worldwide Multiple Sclerosis Therapeutics Industry to 2027 - by Drug Class, Route of Administration, and Distribution Channel and Geography
April 14, 2021 05:08 ET
|
Research and Markets
Dublin, April 14, 2021 (GLOBE NEWSWIRE) -- The "Multiple Sclerosis Therapeutics Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Drug Class, Route of Administration, and Distribution...